analyst
SM
NASDAQ · SMMT
Summit Therapeutics Inc.
Healthcare · Biotechnology
$17.40
Up+$0.32 (+1.84%)
Updated Sep 16, 2026, 3:14 PM
SID Score
5.8/10
Composite research score
Smart Money
55/100
Neutral
- Market cap
- 13.39B
- P/E ratio
- -14.51
- Dividend yield
- 0.00%
- 52-week range
- $12.07 – $29.23
- Volume
- 5.8M
- Avg. volume
- 3.43M
Price performance
SMMT price history
1M range · 20 trading sessions · Daily adjusted prices
SMMT closed at $17.40 after 20 trading sessions, up 35.73% for the selected period.
- Last close
- $17.40
- Period change
- +35.73%
- Period low
- $12.43
- Period high
- $18.42
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $18.16 | $18.47 | $17.11 | $17.40 | 5.8M |
| Sep 14, 2026 | $18.07 | $18.83 | $17.97 | $18.42 | 7.07M |
| Sep 11, 2026 | $17.20 | $17.70 | $17.1375 | $17.55 | 4.28M |
| Sep 10, 2026 | $17.30 | $17.6208 | $16.80 | $17.00 | 4.22M |
| Sep 9, 2026 | $18.205 | $18.3216 | $17.24 | $17.54 | 4.8M |
| Sep 8, 2026 | $17.43 | $17.69 | $16.967 | $17.28 | 7.36M |
| Sep 4, 2026 | $16.935 | $17.63 | $16.80 | $17.605 | 6.95M |
| Sep 3, 2026 | $15.52 | $17.35 | $15.515 | $17.13 | 14.92M |
| Sep 2, 2026 | $14.15 | $14.72 | $14.06 | $14.60 | 3.78M |
| Sep 1, 2026 | $13.38 | $14.475 | $13.37 | $14.16 | 4.7M |
| Aug 31, 2026 | $13.51 | $13.73 | $13.44 | $13.62 | 5.43M |
| Aug 28, 2026 | $14.11 | $14.24 | $13.43 | $13.73 | 3.91M |
| Aug 27, 2026 | $14.30 | $14.65 | $13.92 | $14.33 | 4.84M |
| Aug 26, 2026 | $14.75 | $15.10 | $14.1137 | $14.23 | 11.63M |
| Aug 25, 2026 | $13.27 | $13.60 | $13.05 | $13.36 | 6.33M |
| Aug 24, 2026 | $13.08 | $13.21 | $12.22 | $12.73 | 4.39M |
| Aug 21, 2026 | $12.69 | $13.53 | $12.57 | $13.16 | 7.07M |
| Aug 20, 2026 | $13.01 | $13.02 | $12.285 | $12.43 | 6.57M |
| Aug 19, 2026 | $13.31 | $13.39 | $12.92 | $13.11 | 5.43M |
| Aug 18, 2026 | $12.60 | $13.00 | $12.53 | $12.82 | 4.6M |
Latest SMMT news
The latest Smart Investors Daily articles mentioning SMMT.
Stock researchResearch & News · SEC Filings
Loading stock research…